期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Hasse书写试验在精神科的临床应用 被引量：1

Application of Hasse Band Writing Test in psychiatry
下载PDF
导出
摘要 目的 探讨赫氏书写试验在临床应用的可能性。方法 对正常对照和不同的抗精神病药物治疗的患者各10例进行书写试验进行比较分析。结果 应用高效价抗精神病药物能明显影响字体大小,与剂量、疗效及副反应存在一定相关。结论 赫氏书写试验可作为临床上判断药物疗效及副反应的有用工具。 Objectives: To explore the feasibility of Hasse Writing Test in psychiatric practice. Method: 10 patients taking various antisychotics were asked to take Hasse Writing Test, compared with 10 health controls. Results: The use of high potent antipsychotics had a significant effect on the magnitude of words written and was related to dose, efficacy and side effects. Conclusion: Hasse Writing Test can be a useful tool for evaluating the effectiveness and side effects of antipsychotics.
作者 严和骎 徐勇 张新凯
机构地区 上海市精神卫生中心
出处 《上海精神医学》 北大核心 2001年第4期214-216,共3页 Shanghai Archives of Psychiatry
基金 杨森科学基金(99)
关键词 赫氏书写试验 抗精神病药 副反应 Hasse Handwriting Test Antipsychotics Side effects
分类号 R749 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献12

  • 1Arnes TRE. A rating scale for drug-induced akathisia. Brit J Psychiatry, 1989, 154 : 672
  • 2Owning RW, et al. Temporal changes in handwriting size, level of premobid social functioning and intellectural level during treatment in acute schizophrenic. J Nerv Ment Dis, 1966 Jun, 142(6): 526
  • 3Farde L. Nordstrom, et al. positron emission tomographic analysis of central D1 and D2 doparmine receptor occupancy in patients treated with classical neuroleptics and clozapine relation to extrapyramidal side effects. Arch Gen Psychiatry, 1992, 49: 538
  • 4Gallucci RM, et al. Kinematics analysis of handwriting movement in schizophrenic patients. Biol Psychiatry, 1997 April 1, 41(7) :830
  • 5Gerken A, et al. Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test in 22 acutely ill schizophrenic patients. Pharmacopsychiatry, 1991 Jul, 24(4) : 132
  • 6Haase HJ. Follow-up treatment and aftercare of discharged schizophrenic patients. Schizophr Bull, 1980, 6(4) : 619
  • 7Kapur S, et al. Relationship between dopamine D2 occupacy, clinical response, and side effects: a double-blind PET study of firstepisode schizophrenia. Am J Psychiatry, 2000, 157 : 514
  • 8Kustuer U, et al. The handwriting test as an aid to neuroleptic dosage. Int J Clin Pharmacol Ther Toxicol, 1985, 23 (Suppl 1) :534
  • 9Svante Nyberg, et al. Dopamine Receptor Occupacy during lowdose treatment with Haloperidol Deconate. Am J Psychiatry,1994, 36 : 627
  • 10Scherer J, et al. Striatal D2 dopamine receptor occupancy during treatment with typical and atypical neuroleptics. Biol Psychitry,1994, 36: 627

同被引文献9

  • 1Heath RG, Guschwan AF, Coffey JW. Relation of taraxein to schizophrenia. Dis Nerv Sys, 1970, 31(6) : 391 -395.
  • 2Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiat, 1984, 19(12): 1601-1621.
  • 3Haase HJ. Follow - up treatment and aftercare of discharged schizophrenia patents. Sehizophr Bull, 1980, 6(4) : 619 -626.
  • 4Reynods LM, Cochran SM, Morris B J, et al. Chronic phencyclidine administration induces schizophrenia - like changes in N - acetylaspartate and N - acetylaspartylglutamate in rat brain. Schizophr ReB, 2005, 73(2 -3) : 147 -152.
  • 5Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology : on the matter of their convergence. Mol Psyehiat, 2005, 10(1) : 40 -68.
  • 6Fatemi SH, Stary JM, Earle JA, et al. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res, 2005, 72 (2 - 3 ) : 109 - 122.
  • 7Zhao Xu, Qin Shengying, Shi Yongyong, et al. Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABAB receptor 1 gene and GABAA receptor subunit t32 gene, with schizophrenia using a universal DNA microarray. Schizophr Res, 2007, 93 ( 1 - 3 ) : 374 - 384.
  • 8Patil ST, Zhang L, Martenyi F, et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med, 2007, 13(19) : 1102 -1107.
  • 9Howes OD, KapurS. The dopamine hypothesis of schizophrenia:version III - the final common pathway. Schizophr Bull, 2009, 35 (3) : 549 -562.

引证文献1

上海精神医学
2001年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部